A new company has been launched to bring people and change management expertise to companies that are not able to …
Healthcare communications agency Seven Stones has launched a new market research company to be run by a former head of …
Health secretary Patricia Hewitt has announced plans for a major public engagement exercise to help make far-reaching changes to primary …
An overwhelming majority of NHS chief executives believe patient choice should be extended to treatment as well as service providers, …
Roche's new oral cancer treatment Tarceva has received a recommendation from the EMEA's advisory committee, paving the way for its …
Pharmaceutical companies found guilty of violating European antitrust laws can expect steeper fines than AstraZeneca, according to a leading law …
A study comparing novel treatment Pargluva with a best-selling diabetes drug has yielded some positive results for the new drug, …
Sanofi-Aventis has submitted its new obesity treatment Acomplia to the European Union and US regulators.Even before its filing Acomplia (rimonabant) …
Novartis says its new multiple sclerosis treatment is more effective than existing drugs in delaying the progress of the disease, …
Pfizer has paid almost $2 billion for a US biopharmaceutical company with two promising anti-infective drugs.The acquisition of Vicuron Pharmaceuticals …
AstraZeneca has been fined E60 million by the European Commission for illegally trying to extend the patent on its ulcer …
Bristol-Myers Squibb has pledged to observe a stricter code of conduct in the promotion of its products to the public …
Two widely used painkillers ibuprofen and naproxen have been linked to increased rates of heart attacks in patients, a new …